What is the best course of treatment for a patient with a low ferritin level indicating iron deficiency anemia?

Treatment of Low Ferritin Level

For patients with low ferritin indicating iron deficiency, oral iron supplementation at 100 mg elemental iron daily (or on alternate days for better absorption) is first-line treatment in most cases, while intravenous iron is preferred when active inflammation is present, oral iron is not tolerated, or rapid correction is needed. 1, 2, 3

Diagnostic Confirmation and Context

Before initiating treatment, confirm the diagnosis and assess for underlying inflammation:

• Ferritin <30 μg/L without inflammation confirms iron deficiency in adults over 15 years 1, 4
• Ferritin up to 100 μg/L may still represent true iron deficiency when inflammation is present (measure C-reactive protein to assess inflammatory burden) 1, 5
• Transferrin saturation <20% supports iron deficiency, particularly when ferritin interpretation is complicated by inflammation 5, 2
• In children 6-12 years use ferritin cut-off of 15 μg/L; for adolescents 12-15 years use 20 μg/L 4

Treatment Algorithm

First-Line: Oral Iron Therapy

Use oral iron when:

• No active inflammatory disease is present 1
• Hemoglobin >100 g/L (mild anemia only) 1
• No prior intolerance to oral iron 1
• Patient can absorb oral iron (no malabsorptive conditions) 3

Dosing:

• 100 mg elemental iron per day maximum (e.g., ferrous sulfate 325 mg contains 65 mg elemental iron, so 1-2 tablets daily) 1, 6
• Alternate-day dosing improves absorption and reduces side effects compared to daily dosing 1, 2
• Continue for 3-6 months to replete iron stores 3

Preferred: Intravenous Iron Therapy

Use IV iron when:

• Active inflammatory or autoimmune disease is present (inflammatory bowel disease, chronic kidney disease, heart failure) 1, 5, 3
• Hemoglobin <100 g/L 1
• Previous intolerance to oral iron (occurs in ~50% of patients) 1, 2
• Malabsorption conditions (celiac disease, post-bariatric surgery, atrophic gastritis) 3, 7
• Ongoing blood loss 3
• Second or third trimester of pregnancy 3
• Heart failure patients (improves exercise capacity independent of anemia correction) 2, 3

Dosing:

• Single dose of 1000 mg elemental iron using ferric carboxymaltose over 15 minutes is the evidence-based approach 1
• Dose calculation should be based on hemoglobin level and body weight 1
• Hypersensitivity reactions to newer IV iron formulations are rare (<1%) 2

Critical Pitfalls to Avoid

• Do NOT supplement iron when ferritin >100 μg/L with transferrin saturation >20% - this indicates anemia of chronic disease, not iron deficiency, and supplementation is potentially harmful 1, 5
• Avoid oral iron in active inflammatory bowel disease or other active autoimmune conditions - it may exacerbate disease activity and is poorly absorbed 1, 5
• Do not use test doses with modern IV iron formulations (ferric carboxymaltose, iron sucrose, ferric gluconate) - only iron dextran requires a 25 mg test dose 5
• Avoid maintaining TSAT >50% or ferritin >800 ng/mL chronically - this risks iron overload 5

Monitoring Strategy

Initial response assessment:

• Recheck hemoglobin and iron indices at 8-10 weeks after starting treatment (oral or IV) 1, 4
• Expect hemoglobin increase of 1-2 g/dL if treatment is effective 2
• If no response to oral iron, switch to IV iron 2, 3

Long-term surveillance:

• Every 3 months for the first year after correction 1
• Every 6-12 months thereafter in stable disease 1, 4

Re-treatment thresholds:

• Ferritin drops below 100 μg/L, or 1
• Hemoglobin falls below 120 g/dL (women) or 130 g/dL (men) 1

Proactive Maintenance Approach

For patients with recurrent iron deficiency (particularly inflammatory bowel disease, chronic kidney disease, heavy menstrual bleeding):

• Proactive iron maintenance prevents anemia recurrence more effectively than "watch and wait" strategies 5, 1
• Administer 500 mg IV iron when ferritin falls below 100 μg/L, before anemia develops 5
• This approach reduces healthcare costs (anemic patients cost >2× non-anemic patients) and improves quality of life 5

Investigate Underlying Causes

• Rapid recurrence despite adequate supplementation indicates subclinical inflammatory activity - investigate and treat the underlying condition 5, 1
• In younger patients with plausible cause (heavy menstrual bleeding), treat the bleeding source and provide iron 2
• In men and postmenopausal women, perform bidirectional endoscopy to identify gastrointestinal blood loss 2, 3
• Test for Helicobacter pylori and celiac disease - both are common reversible causes 2, 7
• Recurrent blood loss accounts for 94% of iron deficiency cases 2